Rankings
▼
Calendar
ZTS FY 2020 Earnings — Zoetis Inc. Revenue & Financial Results | Market Cap Arena
ZTS
Zoetis Inc.
$52B
FY 2020 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$6.7B
+6.6% YoY
Gross Profit
$4.5B
66.8% margin
Operating Income
$2.3B
34.0% margin
Net Income
$1.6B
24.5% margin
EPS (Diluted)
$3.42
Cash Flow
Operating Cash Flow
$2.1B
Free Cash Flow
$1.7B
Stock-Based Comp.
$59M
Balance Sheet
Total Assets
$13.6B
Total Liabilities
$9.8B
Stockholders' Equity
$3.8B
Cash & Equivalents
$3.6B
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$6.7B
$6.3B
+6.6%
Gross Profit
$4.5B
$4.1B
+8.4%
Operating Income
$2.3B
$2.0B
+12.4%
Net Income
$1.6B
$1.5B
+9.2%
← Q4 2019
All Quarters
Q1 2020 →